WE HELP YOU KEEP YOUR FEET
VOTIS is seeking investigators to lead clinical trials of our medical device for PAD diagnosis.
Would you like to participate as an investigator in our clinical trials?
VOTIS is a revolutionary new tool to safely screen, stage, and monitor the diabetic foot.
VOTIS provides a clinical decision support for diagnosis and monitoring of diabetic foot syndrome and related conditions.
VOTIS is designed for safe and repeated use over time, and for acute use during surgical procedures.
VOTIS provides objective, repeatable, and measurable data useful to the doctor — regardless of treatment options being used.
VOTIS is non-invasive and ionizing-radiation-free.
Need
Chronic limb-threatening ischemia (CLTI) is an end-stage condition of peripheral artery disease (PAD), which hinders blood flow in the arteries of the leg.
PAD affects more than 200 MILLION PEOPLE worldwide.
CLTI affects 20 MILLION PEOPLE worldwide, 5 MILLION in the US and Europe.
75 THOUSAND non-major amputations (about 2/3 of all amputations) are performed each year in the US.
Solution
VOTIS accompanies the PAD/CLTI patient throughout the patient journey.
P e d C h e c k T
The patient’s feet are screened for Peripheral Artery Disease.
Most likely, the patient is diabetic and 50 years old or older, or is younger but has had active diabetes for 10 years, or is younger and smokes.
P e d S t a g e T M
The patient’s specialists assess blood flow, oxygen flow in the foot, severity of ulcers or gangrene, and infection.
The health of the patient’s foot is assessed regularly for clinical decision support as various treatment options are applied.
P e d F l o T M
The doctor performing revascularization, bypass, open surgery, or minor or partial amputation uses the PedFlo™ to assess blood flow in the foot in real time.
For the first time, doctors can properly see what they are doing:.
P e d S t a g e ™ shows precise location and severity of disease.
An angiosome is an anatomical unit of tissue fed by a source artery and drained by specific veins.
The foot is divided into multiple angiosomes.
By identifying which areas of the foot lack perfusion, the doctor can identify occluded arteries in the leg.
P e d F l o ™ highlights significant changes to blood flow in real time.
Portable, inexpensive, easy-to-use
Votis is an inexpensive portable device
Single-use consumable patches affixed to foot encase reusable laser diodes and photodetector sensors that automatically measure scattering and absorption of the light.
Data is automatically converted into 3-digit (0-3) Wound, Ischemia, Foot-Infection (WIFI) Scale score.
Technology
Solid IP position
Protects VOTIS technology and creates competitive barrier to entry.
Seven issued US patents licensed from Columbia University cover hardware, software and cloud-based AI.
License includes proprietary devices and processes developed in the lab and in the field during studies of human subjects.
Viable development plan to bring screening, staging, and intraoperative devices to market.
Team
Merrill Weber, JD
Co-Founder, CEO & President
Previously, president of vascular medical device company sold for >$100 million.
Andreas H. Hielscher, PhD
Co-Founder & Chief Technology Advisor
Professor of Biophotonics, Columbia University.
Device inventor.
Prof. Brian Glenville, MD
Executive Chairman
Cardiothoracic surgeon, Jerusalem and London, advisor to start-ups and investors.
Mashiach Hakimi, MBA
Chief of Product
20+-year technology industry veteran in strategy, product management, business development, customer success, and engineering.
Karen De Hiep
Marketing Director
Hamutal Shahar, PhD
Chief Clinical Officer
Experienced with scientific and operational management of worldwide clinical trials. Extensive background in medical device, medical technology and drug studies.
Ephraim Siegel
MS Software Architect
Bezalel Jacobowitz
Chief Financial Officer
Accountant with more than 30 years of international operational and business development experience.
Steve Epstein
MSEE
Cisco Systems Expert in Cloud computing, AI and Large Data Transfer Architecture.
David G. Armstrong
DPM, MD, PhD
Leading global expert in amputation prevention and diabetic foot. Professor, USC.
Danielle Bajakian
MD, FACC
Surgical medical advisor; vascular surgeon and Director, Critical Limb Ischemia Program at Columbia University.
Roberto Ferraresi
MD
Tomas Serena
SCIENTIFIC ADVISORY BOARD
DAVID ARMSTRONG
DANIELLE BAJAKIAN
ROBERTO FERRARESI
BRIAN GLENVILLE
ANDREAS HIELSCHER
BOARD OF DIRECTORS
BRIAN GLENVILLE (Executive Chairman)
EDWARD KAPLAN
JERRY KOKOSHKA (Observer)
YARON SUISSA
MERRILL WEBER
CLAUDIO ZUCCOLOTTO
News
May 2022
November 2021
Interview with CEO Merrill Weber for Diabetes Awareness Month on i24 News
June 2021
Votis Subdermal Imaging Technologies Raises US$2.5 Million
December 2020
VOTIS Subdermal Imaging Technologies And ii Ventures Announce Plans To Develop Preventative Medicine Devices To Screen For Peripheral Artery Disease In India
August 2020
Helping diabetics keep their feet
August 2020
Diabetic foot ulcer management in a multidisciplinary foot centre: one-year healing, amputation and mortality rate
Contact
